Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,123 | 43,651 | 33,088 | 44,001 | 218,375 |
| Marketable Securities | 387,174 | 331,307 | 339,503 | 329,401 | 187,851 |
| TOTAL | $480,836 | $383,403 | $377,418 | $377,422 | $409,607 |
| Non-Current Assets | |||||
| PPE Net | 25,162 | 16,245 | 13,323 | 14,860 | 14,923 |
| Investments And Advances | 147,881 | 142,173 | 178,703 | 219,406 | 60,750 |
| Other Non-Current Assets | 8,105 | 2,654 | 2,611 | 2,265 | 1,441 |
| TOTAL | $181,148 | $161,072 | $194,637 | $236,531 | $77,114 |
| Total Assets | $661,984 | $544,475 | $572,055 | $613,953 | $486,721 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,891 | 3,354 | 9,176 | 1,377 | 2,716 |
| Accrued Expenses | N/A | 7,393 | 5,537 | 4,425 | 5,364 |
| Other current liabilities | 30,895 | 20,870 | 16,295 | 11,365 | 6,084 |
| TOTAL | $32,786 | $31,617 | $31,008 | $17,167 | $14,164 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 82,353 | 51,679 | 50,775 | 57,758 | 6,761 |
| TOTAL | $82,353 | $51,679 | $50,775 | $57,758 | $6,761 |
| Total Liabilities | $115,139 | $83,296 | $81,783 | $74,925 | $20,925 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,289 | 94,957 | 94,807 | 94,442 | N/A |
| Common Shares | 1,273 | 1,266 | 1,259 | 1,252 | 1,201 |
| Retained earnings | -227,937 | -305,470 | -270,099 | -215,375 | -191,697 |
| Other shareholders' equity | -649 | -1,416 | -1,493 | -1,287 | -368 |
| TOTAL | $546,845 | $461,179 | $490,272 | $539,028 | $465,796 |
| Total Liabilities And Equity | $661,984 | $544,475 | $572,055 | $613,953 | $486,721 |